Table 3. Linear Regression Model for Differentially Expressed HDL Proteins and Stroke Recovery Swcores.
Protein | Adj. R2 | Intercept | (SE) | F statistic | (DF) | P value | Adj. P value |
---|---|---|---|---|---|---|---|
APOF | 0.734 | −6.51 | (3.32) | 24.41 | (15) | 1.92E-05 | 7.30E-04 |
APOL1 | 0.599 | 0.78 | (4.08) | 13.72 | (15) | 4.10E-04 | 0.008 |
APMAP | 0.413 | 1.80 | (5.13) | 6.99 | (15) | 0.007 | 0.041 |
LPA | 0.599 | −8.40 | (5.22) | 9.96 | (10) | 0.004 | 0.041 |
APOC4 | 0.411 | 6.15 | (5.93) | 6.93 | (15) | 0.007 | 0.041 |
APOM | 0.399 | −1.38 | (4.91) | 6.64 | (15) | 0.009 | 0.041 |
PCYOX1 | 0.452 | 1.26 | (4.86) | 8.01 | (15) | 0.004 | 0.041 |
PON1 | 0.401 | −1.76 | (4.89) | 6.68 | (15) | 0.008 | 0.041 |
APOE | 0.380 | 1.22 | (5.23) | 6.21 | (15) | 0.011 | 0.046 |
Model: NIHSS-3 months ≈NIHSS baseline + protein Log2FC. APMAP indicates adipocyte plasma membrane-associated protein; APOE, apolipoprotein E; APOF, apolipoprotein F; HDL, high-density lipoprotein; NIHSS, National Institutes of Health Stroke Scale; and PON1, serum paraoxonase/ arylesterase.